医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

医学

Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions

Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions

その他ヘルスバイオテクノロジーヘルスケアヘルス一般腫瘍学臨床試験製薬　 TimeLine: an Orally-Administered Gastrointestinal Apros Therapeutics Announces CRC IND Clearance Liver-Targeted TLR7

2020年09月09日

无惧疫情阴霾香港赢得多个大型国际会展活动选址为举办城市

无惧疫情阴霾香港赢得多个大型国际会展活动选址为举办城市

ヘルスケア心臓学放射線学　 TimeLine: 无惧疫情阴霾香港赢得多个大型国际会展活动选址为举办城市

2020年09月08日

Hong Kong Secures Multiple First-Ever MICE Events Amidst COVID-19 Challenges

Hong Kong Secures Multiple First-Ever MICE Events Amidst COVID-19 Challenges

ヘルスケア心臓学放射線学　 TimeLine: Challenges Hong Kong Secures Multiple First-Ever MICE Events Amidst COVID

2020年09月08日

CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy Research Agreement with UMass Medical School

CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy Research Agreement with UMass Medical School

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy Research Agreement with UMass Medical School

2020年09月08日

福岛SiC应用技研株式会社在C轮融资中筹得3,000万美元（31亿日元）

福岛SiC应用技研株式会社在C轮融资中筹得3,000万美元（31亿日元）

ヘルスケア医療機器放射線学腫瘍学臨床試験　 TimeLine: 000万美元 31亿日元福岛SiC应用技研株式会社在C轮融资中筹得3

2020年09月08日

Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD

Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD

バイオテクノロジーヘルスケア医療機器腫瘍学製薬　 TimeLine: $562 million Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately USD

2020年09月08日

Zion Pharma Announces Initiation of Phase 1 Study

Zion Pharma Announces Initiation of Phase 1 Study

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Study Zion Pharma Announces Initiation of Phase

2020年09月08日

赞荣医药宣布启动临床一期研究

赞荣医药宣布启动临床一期研究

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: 赞荣医药宣布启动临床一期研究

2020年09月08日

Fukushima SiC Applied Engineering Inc. Raises USD 30 Million (JPY 3.1 Billion) in Series C Funding

Fukushima SiC Applied Engineering Inc. Raises USD 30 Million (JPY 3.1 Billion) in Series C Funding

ヘルスケア医療機器放射線学腫瘍学臨床試験　 TimeLine: Fukushima SiC Applied Engineering Inc Million Raises USD

2020年09月08日

Chennai Boy Undergoes First of Its Kind Living Donor Liver Transplant in India for Rare Metabolic Disease

Chennai Boy Undergoes First of Its Kind Living Donor Liver Transplant in India for Rare Metabolic Disease

その他ヘルスヘルスケアヘルス一般外科病院遺伝学　 TimeLine: Chennai Boy Undergoes First of Its Kind Living Donor Liver Transplant in India for Rare Metabolic Disease

2020年09月05日